Login Register Cart 0
Generic placeholder image

Reviews on Recent Clinical Trials

Editor-in-Chief

ISSN (Print): 1574-8871
ISSN (Online): 1876-1038

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Clinical Trial

Comparison of the Effects of Govarcin Herbal Capsule and Metoclopramide for Alleviating Gastrointestinal Symptoms in Patients with Functional Dyspepsia: A Randomized Double-blind Clinical Trial

Author(s): Majid Asghari, Sajjad Ahmadpour, Mikaeil Molazadeh, Mohammad Mehdi Jafari, Ahmad Hormati, Mohammad Reza Pashaei, Yousef Mohammadpour, Mohammad Amin Habibi, Abolfazl Mohammadbeigi and Seyed Mahmoud Eshagh Hoseini*

Volume 19, Issue 2, 2024

Published on: 01 December, 2023

Page: [143 - 149] Pages: 7

DOI: 10.2174/0115748871266848231120112355

Price: $65

Abstract

Background: Functional dyspepsia (FD) is felt as a discomfort or pain on the center line or upper abdomen. In this study, we aimed to compare the effects of Govarcin herbal capsule and Metoclopramide for alleviating gastrointestinal symptoms in patients with FD.

Methods: Totally, 106 patients enrolled in a double-blind, clinical trial study. The participants had FD and were divided into two groups receiving Govarcin and Metoclopramide by block randomization. The patients were treated for four weeks, taking one Govarcin capsule or Metoclopramide tablet after each meal. The rate of improvement in patients was assessed by mitigation of clinical symptoms, including epigastric pain, fullness, discomfort, nausea, vomiting and heartburn. Also, before and after intervention, we used Nepin questionnaire and ROME III. SPSS statistics 25 software was used for data analyzing.

Results: Clinical symptom score changes between Govarcin and Metoclopramide patients’ groups showed that there was no significant difference in any of the clinical symptom scores (except for heartburn, p-value=0.012) between the study groups. Nepean score in Govarcin group before and after treatment were 19.3±4.8 and 8.9±2.8, respectively (p-value<0.001). For Metoclopramide group, these values were 19.8±3.5 and 9.4±2.1 respectively (p-value<0.001). No significant difference was found in terms of Nepean score between the Govarcin and Metoclopramide groups (p-value=0.995).

Conclusion: Govarcin herbal capsule can be used to remedy symptoms in patients with FD. It seems that Govarcin is as effective as Metoclopramide in fighting symptoms of FD as no significant difference in efficacy has been demonstrated between them.

« Previous Next »
[1]
Oh JH, Kwon JG, Jung H-K, et al. Functional dyspepsia research G, clinical practice guidelines group under the Korean Society of N, motility. Clinical practice guidelines for functional dyspepsia in Korea. J Neurogastroenterol Motil 2020; 26(1): 29-50.
[http://dx.doi.org/10.5056/jnm19209] [PMID: 31917913]
[2]
Pesce M, Cargiolli M, Cassarano S, et al. Diet and functional dyspepsia: Clinical correlates and therapeutic perspectives. World J Gastroenterol 2020; 26(5): 456-65.
[http://dx.doi.org/10.3748/wjg.v26.i5.456] [PMID: 32089623]
[3]
Wauters L, Talley NJ, Walker MM, Tack J, Vanuytsel T. Novel concepts in the pathophysiology and treatment of functional dyspepsia. Gut 2020; 69(3): 591-600.
[http://dx.doi.org/10.1136/gutjnl-2019-318536] [PMID: 31784469]
[4]
Zhang J, Wu HM, Wang X, et al. Efficacy of prebiotics and probiotics for functional dyspepsia: A systematic review and meta-analysis. Medicine 2020; 99(7): e19107.
[http://dx.doi.org/10.1097/MD.0000000000019107]
[5]
Ford AC, Moayyedi P, Black CJ, et al. Systematic review and network meta-analysis: Efficacy of drugs for functional dyspepsia. Aliment Pharmacol Ther 2021; 53(1): 8-21.
[http://dx.doi.org/10.1111/apt.16072] [PMID: 32936964]
[6]
Carbone F, Vanuytsel T, Tack J. Analysis of postprandial symptom patterns in subgroups of patients with Rome III or rome IV functional dyspepsia. Clin Gastroenterol Hepatol 2020; 18(4): 838-846.e3.
[http://dx.doi.org/10.1016/j.cgh.2019.07.053] [PMID: 31394286]
[7]
Tziatzios G, Gkolfakis P, Papanikolaou IS, et al. Gut microbiota dysbiosis in functional dyspepsia. Microorganisms 2020; 8(5): 691.
[http://dx.doi.org/10.3390/microorganisms8050691] [PMID: 32397332]
[8]
Bauer M, Bamminger K, Pichler V, et al. Impaired clearance from the brain increases the brain exposure to metoclopramide in elderly subjects. Clin Pharmacol Ther 2021; 109(3): 754-61.
[http://dx.doi.org/10.1002/cpt.2052] [PMID: 32966590]
[9]
Ge S, Mendley SR, Gerhart JG, et al. Best pharmaceuticals for children act-pediatric trials network steering committee. Population pharmacokinetics of metoclopramide in infants, children, and adolescents. Clin Transl Sci 2020; 13(6): 1189-98.
[http://dx.doi.org/10.1111/cts.12803] [PMID: 32324313]
[10]
Sharangi AB, Das S. Healing indigestion: A phytotherapeutic review. Adv Trad Med 2022; 22(3): 437-53.
[http://dx.doi.org/10.1007/s13596-020-00514-x]
[11]
Ford AC, Luthra P, Tack J, Boeckxstaens GE, Moayyedi P, Talley NJ. Efficacy of psychotropic drugs in functional dyspepsia: Systematic review and meta-analysis. Gut 2017; 66(3): 411-20.
[http://dx.doi.org/10.1136/gutjnl-2015-310721] [PMID: 26567029]
[12]
Pourkhaje A. Evolving approach to dyspepsia and nonulcer dyspepsia. GOVARESH 2017; 2(11&12): 33-40.
[13]
Jones RH. Approaches to uninvestigated dyspepsia. Gut 2002; 50 (Suppl 4): iv42-6.
[PMID: 11953347]
[14]
Bektas M, Soykan I, Altan M, Alkan M, Özden A. The effect of Helicobacter pylori eradication on dyspeptic symptoms, acid reflux and quality of life in patients with functional dyspepsia. Eur J Intern Med 2009; 20(4): 419-23.
[http://dx.doi.org/10.1016/j.ejim.2008.11.007] [PMID: 19524187]
[15]
Feinle-Bisset C, Vozzo R, Horowitz M, Talley NJ. Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol 2004; 99(1): 170-81.
[http://dx.doi.org/10.1111/j.1572-0241.2004.04003.x] [PMID: 14687160]
[16]
Miwa H. Why dyspepsia can occur without organic disease: Pathogenesis and management of functional dyspepsia. J Gastroenterol 2012; 47(8): 862-71.
[http://dx.doi.org/10.1007/s00535-012-0625-9] [PMID: 22766746]
[17]
Miwa H, Watari J, Fukui H, et al. Current understanding of pathogenesis of functional dyspepsia. J Gastroenterol Hepatol 2011; 26 (Suppl. 3): 53-60.
[http://dx.doi.org/10.1111/j.1440-1746.2011.06633.x] [PMID: 21443711]
[18]
Camilleri M. Functional dyspepsia: Mechanisms of symptom generation and appropriate management of patients. Gastroenterol Clin North Am 2007; 36(3): 649-664, xi-x.
[http://dx.doi.org/10.1016/j.gtc.2007.07.001] [PMID: 17950442]
[19]
Sun J, Gou J, Liu LQ, et al. Excretion of Cynanchum auriculatum extract in urine and feces of normal and functional dyspepsia rats. Zhongguo Zhongyao Zazhi 2022; 47(23): 6355-64.
[PMID: 36604880]
[20]
Li X, Lin Y, Jiang Y, Wu B, Yu Y. Aqueous extract of Phyllanthus emblica L. Alleviates functional dyspepsia through regulating gastrointestinal hormones and gut microbiome in vivo. Foods 2022; 11(10): 1491.
[http://dx.doi.org/10.3390/foods11101491] [PMID: 35627061]
[21]
Shin J, Oh TH, Kim JY, Shim JJ, Lee JL. Efficacy and safety of the Cudrania tricuspidata extract on functional dyspepsia: A randomized double-blind placebo-controlled multicenter study. J Clin Med 2021; 10(22): 5323.
[http://dx.doi.org/10.3390/jcm10225323] [PMID: 34830605]
[22]
Khonche A, Fallah Huseini H, abdi H, Mohtashami R, Nabati F, Kianbakht S. Efficacy of Mentha pulegium extract in the treatment of functional dyspepsia: A randomized double-blind placebo-controlled clinical trial. J Ethnopharmacol 2017; 206: 267-73.
[http://dx.doi.org/10.1016/j.jep.2017.05.026] [PMID: 28571727]
[23]
Asari S. Effect of Ocimum Basilicum extract on treatment of functional dyspepsia. Shahrekord Univ Med Sci J 2002; 4(3): 14-20.
[24]
Fani A, Fani I, Fani P, Alizade B, Rafei M, Malekirad A. A clinical-controlled trial compared carom caraway (black cumin, Niggella sativa) and metoclopramide in functional dyspepsia. Int J Med Med Sci 2010; 2(12): 391-4.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy